Chemoinformatic Characterization of the Chemical Space and Molecular Diversity of Compound Libraries

[1]  A. Schuffenhauer,et al.  Complex molecules: do they add value? , 2005, Current opinion in chemical biology.

[2]  Tudor I. Oprea,et al.  Scaffold Topologies. 2. Analysis of Chemical Databases , 2008, J. Chem. Inf. Model..

[3]  R A Houghten,et al.  Mixture-based synthetic combinatorial libraries. , 1999, Journal of medicinal chemistry.

[4]  José L. Medina-Franco,et al.  Structure–activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps , 2011 .

[5]  J. Bajorath,et al.  Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.

[6]  Austin B. Yongye,et al.  Characterization of a comprehensive flavor database , 2011 .

[7]  Stuart L. Schreiber,et al.  Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections , 2011, Proceedings of the National Academy of Sciences.

[8]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[9]  Jun Xu.  A new approach to finding natural chemical structure classes. , 2002, Journal of medicinal chemistry.

[10]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Veerabahu Shanmugasundaram,et al.  Molecular similarity measures. , 2011, Methods in molecular biology.

[12]  Ricardo Macarron,et al.  Critical review of the role of HTS in drug discovery. , 2006, Drug discovery today.

[13]  Alan L Harvey,et al.  The Drug Discovery Portal: a resource to enhance drug discovery from academia. , 2010, Drug discovery today.

[14]  J. Mason,et al.  New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.

[15]  José L Medina-Franco,et al.  Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets. , 2012, Bioorganic & medicinal chemistry.

[16]  Peter Ertl,et al.  Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping. , 2012, Bioorganic & medicinal chemistry.

[17]  Evan Bolton,et al.  PubChem's BioAssay Database , 2011, Nucleic Acids Res..

[18]  Jürgen Bajorath,et al.  Lessons Learned from Molecular Scaffold Analysis , 2011, J. Chem. Inf. Model..

[19]  Miklos Feher,et al.  Consensus scoring for protein-ligand interactions. , 2006, Drug discovery today.

[20]  Alan L Harvey,et al.  Current strategies for drug discovery through natural products , 2010, Expert opinion on drug discovery.

[21]  Alban Arrault,et al.  Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers , 2006, Molecular Diversity.

[22]  Ola Engkvist,et al.  A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds , 2012 .

[23]  Steven H. Bertz,et al.  The first general index of molecular complexity , 1981 .

[24]  Mark Johnson,et al.  Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries , 2002, J. Chem. Inf. Comput. Sci..

[25]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[26]  Yongping Yu,et al.  Combinatorial chemistry: libraries from libraries, the art of the diversity-oriented transformation of resin-bound peptides and chiral polyamides to low molecular weight acyclic and heterocyclic compounds. , 2004, The Journal of organic chemistry.

[27]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[28]  Anne E Carpenter.  Image-based chemical screening. , 2007, Nature chemical biology.

[29]  Francesco Marchetti,et al.  Towards the systematic exploration of chemical space. , 2012, Organic & biomolecular chemistry.

[30]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[31]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[32]  Thierry Kogej,et al.  ChemGPS-NPWeb: chemical space navigation online , 2009, J. Comput. Aided Mol. Des..

[33]  Sivaraman Dandapani,et al.  Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. , 2010, Nature chemical biology.

[34]  Sorel Muresan,et al.  ChemGPS-NP: tuned for navigation in biologically relevant chemical space. , 2006, Journal of natural products.

[35]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[36]  Nathan Brown,et al.  On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.

[37]  P. Willett,et al.  Combining multiple classifications of chemical structures using consensus clustering. , 2012, Bioorganic & medicinal chemistry.

[38]  Wolfgang H. B. Sauer,et al.  Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..

[39]  J. Bajorath,et al.  Data structures and computational tools for the extraction of SAR information from large compound sets. , 2010, Drug discovery today.

[40]  Gerald M. Maggiora,et al.  Hierarchical Strategy for Identifying Active Chemotype Classes in Compound Databases , 2006, Chemical biology & drug design.

[41]  Stuart L Schreiber,et al.  Generating Diverse Skeletons of Small Molecules Combinatorially , 2003, Science.

[42]  Anang A Shelat,et al.  The interdependence between screening methods and screening libraries. , 2007, Current opinion in chemical biology.

[43]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[44]  Tudor I. Oprea,et al.  Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry , 2005, J. Chem. Inf. Model..

[45]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[46]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[47]  Mark Johnson,et al.  Algorithm for Naming Molecular Equivalence Classes Represented by Labeled Pseudographs , 2001, J. Chem. Inf. Comput. Sci..

[48]  Gemma L Thomas,et al.  Natural product-like synthetic libraries. , 2011, Current opinion in chemical biology.

[49]  Ian T. Nabney,et al.  Data Visualization during the Early Stages of Drug Discovery , 2006, J. Chem. Inf. Model..

[50]  Wolfgang H. B. Sauer,et al.  Size doesn't matter: Scaffold diversity shape diversity, and biological activity of combinatorial libraries , 2003 .

[51]  W. Pitt,et al.  Heteroaromatic rings of the future. , 2009, Journal of medicinal chemistry.

[52]  J. Gasteiger,et al.  Prediction of Aqueous Solubility of Organic Compounds by Topological Descriptors , 2003 .

[53]  Clemencia Pinilla,et al.  A Similarity‐based Data‐fusion Approach to the Visual Characterization and Comparison of Compound Databases , 2007, Chemical biology & drug design.

[54]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[55]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[56]  J. Medina-Franco,et al.  Expanding the medicinally relevant chemical space with compound libraries. , 2012, Drug discovery today.

[57]  José L. Medina-Franco,et al.  Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..

[58]  Austin B. Yongye,et al.  Multitarget Structure-Activity Relationships Characterized by Activity-Difference Maps and Consensus Similarity Measure , 2011, J. Chem. Inf. Model..

[59]  Peter Ertl,et al.  Relationships between Molecular Complexity, Biological Activity, and Structural Diversity , 2006, J. Chem. Inf. Model..

[60]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[61]  Jürgen Bajorath,et al.  Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[62]  Stuart L. Schreiber,et al.  Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles , 2010, Proceedings of the National Academy of Sciences.

[63]  Peter Willett,et al.  Chemoinformatics: a history , 2011 .

[64]  Adam Nelson,et al.  Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries , 2008, Natural product reports.

[65]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[66]  Hugo O. Villar,et al.  Substructural Analysis in Drug Discovery , 2007 .

[67]  Rafael Gozalbes.  Editorial [Hot topic: Rational Generation of Focused Chemical Libraries:An Update on Computational Approaches (Guest Editor: Rafael Gozalbes)] , 2011 .

[68]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[69]  Roland E. Dolle,et al.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009. , 2010, Journal of combinatorial chemistry.

[70]  José L. Medina-Franco,et al.  Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure , 2009 .

[71]  Peter Willett,et al.  Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.

[72]  Peter Ertl,et al.  Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.

[73]  Sara H Fitzgerald,et al.  Survey of the diversity space coverage of reported combinatorial libraries. , 2007, Journal of combinatorial chemistry.

[74]  Rafael Gozalbes,et al.  Small molecule databases and chemical descriptors useful in chemoinformatics: an overview. , 2011, Combinatorial chemistry & high throughput screening.

[75]  Tudor I. Oprea,et al.  Chemography: the Art of Navigating in Chemical Space , 2000 .

[76]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[77]  Herbert Waldmann,et al.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[79]  Gisbert Schneider,et al.  Properties and Architecture of Drugs and Natural Products Revisited , 2007 .

[80]  W Patrick Walters,et al.  What do medicinal chemists actually make? A 50-year retrospective. , 2011, Journal of medicinal chemistry.

[81]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[82]  J. Medina-Franco,et al.  Advances in the computational development of DNA methyltransferase inhibitors. , 2011, Drug discovery today.

[83]  Andrew R. Leach,et al.  Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..

[84]  Mathias Wawer,et al.  Navigating structure-activity landscapes. , 2009, Drug discovery today.

[85]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[86]  José L. Medina-Franco,et al.  Benzotriazoles and Indazoles Are Scaffolds with Biological Activity against Entamoeba histolytica , 2011, Journal of biomolecular screening.

[87]  Modest von Korff,et al.  Assessing the Predictive Power of Unsupervised Visualization Techniques to Improve the Identification of GPCR-Focused Compound Libraries , 2006, J. Chem. Inf. Model..

[88]  Daniela Digles,et al.  Self‐Organizing Maps for In Silico Screening and Data Visualization , 2011, Molecular informatics.

[89]  Michal Sabat,et al.  Diversity Space and Its Application to Library Selection and Design , 2006, J. Chem. Inf. Model..

[90]  Lars Bohlin,et al.  Expanding the ChemGPS chemical space with natural products. , 2005, Journal of natural products.

[91]  Jean-Louis Reymond,et al.  A Searchable Map of PubChem , 2010, J. Chem. Inf. Model..

[92]  C. Dobson.  Chemical space and biology , 2004, Nature.

[93]  P. Verhoest,et al.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. , 2010, ACS chemical neuroscience.

[94]  Igor I Baskin,et al.  Chemoinformatics as a Theoretical Chemistry Discipline , 2011, Molecular informatics.

[95]  Peter Ertl,et al.  Evolution of the physicochemical properties of marketed drugs: can history foretell the future? , 2011, Drug discovery today.

[96]  Hongyu Zhao.  Lead optimization in the nondrug-like space. , 2011, Drug discovery today.

[97]  Paul D Leeson,et al.  Time-related differences in the physical property profiles of oral drugs. , 2004, Journal of medicinal chemistry.

[98]  David DeCaprio,et al.  Cheminformatics approaches to analyze diversity in compound screening libraries. , 2010, Current opinion in chemical biology.

[99]  Tudor I. Oprea,et al.  The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.

[100]  R. Glen,et al.  Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.

[101]  José L. Medina-Franco,et al.  Visualization of Molecular Fingerprints , 2011, J. Chem. Inf. Model..

[102]  Joanna Owens,et al.  Chris Lipinski discusses life and chemistry after the Rule of Five. , 2003 .

[103]  Jürgen Bajorath,et al.  Analysis of Chemical Information Content Using Shannon Entropy , 2007 .

[104]  Obdulia Rabal,et al.  Using Novel Descriptor Accounting for Ligand-Receptor Interactions To Define and Visually Explore Biologically Relevant Chemical Space , 2012, J. Chem. Inf. Model..

[105]  M. Jung,et al.  Targeting Epigenetic Mechanisms : Potential of Natural Products in Cancer Chemoprevention , 2008 .

[106]  Andreas Bender,et al.  Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.

[107]  R A Houghten,et al.  "Libraries from libraries": chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[108]  Jean-Louis Reymond,et al.  Cluster analysis of the DrugBank chemical space using molecular quantum numbers. , 2012, Bioorganic & medicinal chemistry.

[109]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..

[110]  Peter Ertl,et al.  The graphical representation of ADME-related molecule properties for medicinal chemists. , 2011, Drug discovery today.

[111]  Yoo Jakyung,et al.  Chemoinformatic Approaches for Inhibitors of DNA Methyltransferases: Comprehensive Characterization of Screening Libraries , 2011 .

[112]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[113]  Dimitris K Agrafiotis,et al.  SAR maps: a new SAR visualization technique for medicinal chemists. , 2007, Journal of medicinal chemistry.

[114]  Clemencia Pinilla,et al.  Advances in the use of synthetic combinatorial chemistry: Mixture-based libraries , 2003, Nature Medicine.

[115]  Thomas Engel,et al.  Basic Overview of Chemoinformatics , 2006, J. Chem. Inf. Model..

[116]  A. Leach,et al.  Molecular complexity and fragment-based drug discovery: ten years on. , 2011, Current opinion in chemical biology.

[117]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[118]  José L. Medina-Franco,et al.  Visualization of the Chemical Space in Drug Discovery , 2008 .

[119]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes , 2012 .

[120]  Vincent Le Guilloux,et al.  Visual Characterization and Diversity Quantification of Chemical Libraries: 1. Creation of Delimited Reference Chemical Subspaces , 2011, J. Chem. Inf. Model..

[121]  Ansgar Schuffenhauer,et al.  Rule‐Based Classification of Chemical Structures by Scaffold , 2011, Molecular informatics.

[122]  J. Bajorath,et al.  Distribution of Molecular Scaffolds and R-Groups Isolated from Large Compound Databases , 1999 .

[123]  José L. Medina-Franco,et al.  Increased Diversity of Libraries from Libraries: Chemoinformatic Analysis of Bis‐Diazacyclic Libraries , 2011, Chemical biology & drug design.

[124]  Lorenz C. Blum,et al.  Classification of Organic Molecules by Molecular Quantum Numbers , 2009, ChemMedChem.

[125]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[126]  James L. Melville,et al.  Better than Random? The Chemotype Enrichment Problem , 2009, J. Chem. Inf. Model..

[127]  Eugen Lounkine,et al.  Chemotography for multi-target SAR analysis in the context of biological pathways. , 2012, Bioorganic & medicinal chemistry.

[128]  Clemencia Pinilla,et al.  Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. , 2008, Journal of combinatorial chemistry.

[129]  Vincent Le Guilloux,et al.  Visual Characterization and Diversity Quantification of Chemical Libraries: 2. Analysis and Selection of Size-Independent, Subspace-Specific Diversity Indices , 2012, J. Chem. Inf. Model..

[130]  Thomas Scior,et al.  Large compound databases for structure-activity relationships studies in drug discovery. , 2007, Mini reviews in medicinal chemistry.

[131]  Sarah R. Langdon,et al.  Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..

[132]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[133]  René Barone,et al.  A New and Simple Approach to Chemical Complexity. Application to the Synthesis of Natural Products , 2001, J. Chem. Inf. Comput. Sci..